P V Ramprasad Reddy and Family

The Reddy family's underlying philosophy has been to command the global generics market through audacious cross-border expansion and the sheer scale of low-cost manufacturing. The Aurobindo narrative is a quintessential rags-to-riches family saga. In 1986, P.V. Ramprasad Reddy—a former commerce graduate and humble clerk—teamed up with relative K. Nityananda Reddy to start a single manufacturing unit in Pondicherry. Through sheer grit and an aggressive appetite for risk, they bet heavily on producing active pharmaceutical ingredients (APIs), quickly becoming an indispensable supplier to the West. 

The family dynamic has been tested and strengthened through complex global acquisitions and regulatory hurdles. Today, the torch is firmly in the hands of the next generation. Ramprasad’s son, Sarath Chandra Reddy, serves as a pivotal full-time director, navigating the fiercely competitive US market and steering the company into complex injectables and biosimilars. The family’s journey from a modest mid-level worker’s dream to controlling a multi-billion-dollar enterprise remains one of the most compelling testaments to Indian entrepreneurial mobility.